Navigation Links
Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial

more than 300 papers in peer-reviewed journals.

Dr. Low is Head of the Department of Microbiology at the Toronto Medical Laboratories and Mount Sinai Hospital. He is also Medical Director, Ontario Public Health Laboratories, Ministry of Health and Long-Term Care. He is a Professor at the University of Toronto in the Department of Laboratory Medicine and Pathobiology and Department of Medicine. He is currently Head of the Division of Microbiology in the Department of Laboratory Medicine and Pathobiology.

About Advanced Life Sciences

Advanced Life Sciences is a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, cancer and inflammation. The Company's lead candidate, cethromycin, is a novel once-a-day antibiotic in late-stage clinical development for the treatment of respiratory tract infections including CAP. For more information, please visit us on the web at http://www.advancedlifesciences.com.

Forward-Looking Statements

Any statements contained in this press release that relate to future plans, events or performance are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, among others, those relating to technology and product development, clinical trials, market acceptance, government regulation and regulatory approval processes, intellectual property rights and litigation, dependence on collaborative relationships, ability to obtain financing, competitive products, industry trends and other risks identified in Advanced Life Sciences' filings with the Securities and Exchange Commission. Advanced Life
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
3. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
4. Advanced Life Sciences to Host Conference Call to Discuss Data From Cethromycins First of Two Phase 3 Pneumonia Trials
5. Progenics and Wyeth Announce Positive Results from Three-Month Clinical-Extension Study of Subcutaneous Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Patients with Advanced Illness
6. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
7. Neurologix Announces Publication of Landmark Gene Therapy Study Demonstrating Safety and Statistically Significant Improvement in Patients With Advanced Parkinsons Disease
8. Advanced Viral Research Corp. Announces Positive Preliminary Findings from Ongoing Phase II Dermatological Study
9. Clinical Data Reported on Vidaza in Hematologic Malignancies and Advanced Solid Tumors
10. Updated Study Results Reinforce Survival Benefit of Taxotere (Docetaxel) for Men with Advanced, Hormone-Resistant Prostate Cancer
11. GSKS Pazopanib Shows Positive Results in Patients with Advanced Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma

Post Your Comments:
(Date:11/6/2009)...IEGO, Nov. 6 Ardea Biosc...pany focused on the development of small-molecule ... human immunodeficiency virus (HIV), today reporte... the third quarter and nine months ended September...cgi-bin/prnh/20091104/ARDEALOGO ) ,, "Since our...
(Date:11/6/2009)...ON, Nov. 6 Cyberonics, I...any will report financial results for the second q...nding April 30, 2010 on Wednesday, November 18, 20...ference call to discuss those results on Thursday,...Year 2010 Second Quarter Results Conference Call I...
(Date:11/6/2009)...IT, Nov. 6 Caraco Pharma... launched ketorolac tromethamine ophthalmic soluti...od and Drug Administration (FDA) for Sun Pharma,s ...c Acular® opthalmic solution on the first day...orolac is therapeutically equivalent to Acular...
Breaking Medicine Technology:Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 2Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 3Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 4Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 5Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 6Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 7Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 8Cyberonics Announces Conference Call to Discuss Fiscal Year 2010 Second Quarter Financial Results 2Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic Solution 2New Isolation Valves With Inert Body And Diaphragm Materials Added To Gems Family 60353 1New Isolation Valves With Inert Body And Diaphragm Materials Added To Gems Family 60353 2New Isolation Valves With Inert Body And Diaphragm Materials Added To Gems Family 60353 3President Selected to Open Sanford Brown Institute Grand Rapids 60350 1President Selected to Open Sanford Brown Institute Grand Rapids 60350 2House Healthcare Bill 3A Government Run Plan Other Key Provisions Undermine Goals of Access and Affordability 60346 1House Healthcare Bill 3A Government Run Plan Other Key Provisions Undermine Goals of Access and Affordability 60346 2House Healthcare Bill 3A Government Run Plan Other Key Provisions Undermine Goals of Access and Affordability 60346 3
.... (NHSi) has won a two-year award of $1.9 million ...of the National Institutes of Health (NIH) to deve...The project aims to develop the Hemanext Anaerobic...lood for transfusion therapy and extends the shelf...onstrated that this new technology can deliver hig...
...ty for Acute Pain Patients , , RARITAN, N.J., May...people who have surgery experience gastrointestina...se of opioid pain medicines during and after surge... side effects. Nausea and vomiting are uncomfortab...ent,s recovery. , , According to a new Phase 3 cl...
Other Medicine Technology:Bethesda-Based NHSi Wins $2M Grant for Blood Technology 2Bethesda-Based NHSi Wins $2M Grant for Blood Technology 3New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 2New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 3New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 4New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 5New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 6New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 7New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 8
(Date:11/7/2009)... , HOUSTON, Nov. 7 ...esented Lisa James, Director of Health at the Fami... Distinguished Service today at its semi-annual po...ed Service is the highest honor the AMA House of D...: http://www.newscom.com/cgi-bin/prnh/20081209/...
(Date:11/7/2009)... , Brown: "Faithful Catholics have a respon...re, not negotiate the status quo." ,, WASHING... Life League president Judie Brown released the fo... Rigali will support Speaker Nancy Pelosi,s Afford...ided an amendment preserving the status quo for ab...
(Date:11/7/2009)...Parents should not assume that all youth will rebe...hDay News) -- Teens are more likely to behave badl...y has found. , "Parents who believe they are simpl...elf-fulfilling prophecy," Christy Buchanan, a psyc...author of the study, said in a university news rel...
(Date:11/7/2009)..., A new foot spray from G...with the power of hot peppers and caffeine. Therma...g natural formula that also contains Black Walnut,... Schenectady, NY (PRWEB) N...ons fights pain and increases circulation with the...
(Date:11/6/2009)..., WHITE PLAINS, N.Y., Nov. 6 The Leukemia &am...ing in Gap Inc.,s Give & Get program, which in...er, garnered more than $1 million to support LLS,s...on and support services. ,, During the campaign, t...ill issue downloadable 30% discount coupons pa...
Breaking Medicine News(10 mins):Health News:AMA Honors Family Violence Prevention Expert 2Health News:Statement Regarding Cardinal Rigali's Memo Protecting the 'Status Quo' On Life 2Health News:Bad-Behaving Teens May Be Living Up to Expectations 2Health News:Hot Peppers and Caffeine Relieve Painful Feet, Toe Fungus and Foot Odor 2Health News:Get a Jump on Your Holiday Shopping and Give Two Gifts This Season: One to Your Loved Ones and One to People Battling Blood Cancer 2
...y the most common neurological disorder and one of...ve million people die of stroke each year and more...the question of the day is about the recovery - wh...n Maryland devised a method which allows doctors t...
...pe I, is due to autoimmune destruction of the panc... this the body no longer produces insulin and and ...duals with this type I Diabetes develop are at a h... Los Angeles did a study involving 57 diabetics ag...
...one of the common neurological problems affecting ...any underlying disease. If you happen to be one of...aine, then there is a reason to celebrate. Yes, th...gress of Neurology told that tizanidine, can cut t...
...umber of advertisements by the drug companies has ... prescription drug ads from television, news paper...w Jersey delegate Dr. Angelo agro said that such a...ded that ads have tuned into a competition "to see...
...n the density of the bone is lost and becomes brit...after they attain their menopause. This happens as...s responsible for maintaining the bone density. ...nt bone loss after menopause as effectively as est...
...is on the rise. But the alarm bells are soaring ag...female smokers with breast cancer face an increase...other organs than do nonsmokers "There is a re...ifornia at Davis. Dr. Murin says the research m...
Other Medicine News:
SureCut M3500 Fuses, Spare
Feather Disposable Blades, Pack of 50
SureCut M3500 Abrasive, Coarse, Knife Sharpening
SureCut M3500 Standard Knife w/ Box, C Profile
Medicine Products: